TrialPLoS neglected tropical diseases2020

A phase 1 randomized safety, reactogenicity, and immunogenicity study of Typhax: A novel protein capsular matrix vaccine candidate for the prevention of typhoid fever.

Robert T Cartee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.